Diagnostic Applications Steadily Capturing the Medical Automation Market; Projected to Increase 44.4% by 2020
April 16, 2015
Wellesley, Mass., April 16, 2015 –BCC Research (www.bccresearch.com) reveals in its new report on the U.S. market for medical automation technologies, that as technology advances, new functions are being added to automated health assessment and monitoring tools. The current generation of automated health assessment and monitoring tools are not intended to substitute the need for a physician or other healthcare professional.
Medical automation technologies are electronics for the electromechanical operation of diagnostic (or therapeutic) systems of healthcare professionals, and which result in a reduced need (or eliminate the need) for human intervention. The U.S. market for such technologies was worth an estimated $16.3 billion in 2014. BCC Research expects this market to grow to $17.5 billion in 2015 and nearly $26.5 billion by 2020, a compound annual growth rate (CAGR) of 8.6% over the next five years.
Therapeutic applications account for the largest share of the medical automation market, 55.2% in 2014, declining to 49% by 2020. Diagnostic and monitoring applications represented 40.7% of the market in 2014, increasing to 44.4% by 2020, with logistics and training holding the remainder.
Automated devices used for therapeutic applications, other than surgery, include automated cardiac defibrillators and medication delivery systems. The use of automated medication delivery systems is intended to reduce medication errors, improve patient compliance with a medication regime and increase patient comfort and convenience.
“Automation is an important tool for clinical laboratories to use for achieving higher productivity and cost-efficiency,” says BCC Research analyst Andrew McWilliams. “Laboratory automation covers a wide range of processes that occur in the lab, from the receipt of the sample to the reporting of the validated results. Specific solutions range from the automation of specific instruments or processes to total laboratory-wide automation.”
Medical Automation Technologies, Products and Markets identifies and quantifies the current and future market opportunities associated with medical automation. Projections of the potential U.S. markets for these technologies are studied through 2020.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Medical Automation Technologies, Products and Markets( HLC066C )
Publish Date: Apr 2015
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- Chronic Kidney Disease: Global Markets and Technologies
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development